State Aid for Gallo Urged CDC Daily UpdateImportant note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




State Aid for Gallo Urged

Baltimore Sun (12/15/95) P. 1C
Frece, John W.


Government and business leaders from Maryland urged approval on Thursday of state funding for Dr. Robert C. Gallo's planned institute of Human Virology. House Appropriations Chairman Howard P. Rawlings and Senate Budget and Taxation Chairwoman Barbara A. Hoffmann anticipated that their committees would approve the initial $3 million needed for the project, which will cost Maryland taxpayers some $24 million in the end. "The implications for humankind are phenomenal," noted Hoffmann. "Any state that gets this team and this institute is going to be automatically in the forefront of the cutting edge of science and technology." The primary goal of the center, which will be part of the University of Maryland Biotechnology Institute, will be to develop "better therapy for HIV-infected people," Dr. Gallo said, adding that research will also focus on viruses that cause some cancers and neurological disorders. Related Story: Washington Post (12/15) P. A10


951215
AD952239


Copyright © 1995 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.